Patents Assigned to MicroSintesis Inc.
  • Probiotic molecules for reducing pathogen virulence
    Patent number: 11912788
    Abstract: Provided are peptides that are derived from probiotic bacteria that have use for preventing and/or treating non-enteric infections in a subject. The peptides derived from the probiotic bacteria also have use for reducing the virulence of non-enteric infections in a subject. Also provided are compositions of the peptides formulated as or within food products, beverages, nutritional supplements, medicaments and the like.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: February 27, 2024
    Assignee: MICROSINTESIS INC.
    Inventors: Monica Angela Cella, Sarah M. Curtis, Jonathon Patrick Roepke
  • Antiviral methods and compositions comprising probiotic bacterial molecules
    Patent number: 11857581
    Abstract: Molecules secreted or derived from probiotic bacteria are provided for use in compositions and methods for the treatment and/or prevention of infection by pathogenic viruses. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.
    Type: Grant
    Filed: June 12, 2020
    Date of Patent: January 2, 2024
    Assignee: MicroSintesis Inc.
    Inventor: Mansel Griffiths